Deokar Angela J, Dellapenna Alan, DeFiore-Hyrmer Jolene, Laidler Matt, Millet Lisa, Morman Sara, Myers Lindsey
Division of Analysis, Research and Practice Integration, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia (Ms Deokar); Injury and Violence Prevention Branch, North Carolina Department of Health and Human Services, Raleigh, North Carolina (Mr Dellapenna), Ohio Violence and Injury Prevention Program, Ohio Department of Health, Columbus, Ohio (Mss Defiore-Hyrmer and Morman); Injury and Violence Prevention Section, Oregon Health Authority, Salem, Oregon (Mr Laidler and Ms Millet); and Violence and Injury Prevention-Mental Health Promotion Branch, Colorado Department of Health and Environment, Denver, Colorado (Ms Myers).
J Public Health Manag Pract. 2018 Jan/Feb;24 Suppl 1 Suppl, Injury and Violence Prevention(Suppl 1 INJURY AND VIOLENCE PREVENTION):S23-S31. doi: 10.1097/PHH.0000000000000704.
The Centers for Disease Control and Prevention's (CDC's) Core Violence and Injury Prevention Program (Core) supports capacity of state violence and injury prevention programs to implement evidence-based interventions. Several Core-funded states prioritized prescription drug overdose (PDO) and leveraged their systems to identify and respond to the epidemic before specific PDO prevention funding was available through CDC. This article describes activities employed by Core-funded states early in the epidemic. Four case examples illustrate states' approaches within the context of their systems and partners. While Core funding is not sufficient to support a comprehensive PDO prevention program, having Core in place at the beginning of the emerging epidemic had critical implications for identifying the problem and developing systems that were later expanded as additional resources became available. Important components included staffing support to bolster programmatic and epidemiological capacity; diverse and collaborative partnerships; and use of surveillance and evidence-informed best practices to prioritize decision-making.
美国疾病控制与预防中心（CDC）的核心暴力与伤害预防项目（Core项目）支持各州暴力与伤害预防项目实施循证干预的能力。几个由Core项目资助的州将处方药过量（PDO）问题列为优先事项，并在CDC提供特定的PDO预防资金之前，利用其系统来识别和应对这一流行病。本文介绍了Core项目资助的州在疫情早期开展的活动。四个案例说明了各州在其系统和合作伙伴背景下的应对方法。虽然Core项目的资金不足以支持全面的PDO预防项目，但在疫情初期设立Core项目对于识别问题和开发系统具有关键意义，这些系统后来随着更多资源的到位而得到扩展。重要组成部分包括提供人员支持以增强项目和流行病学能力；建立多样化的合作关系；以及利用监测和循证最佳实践来确定决策优先级。
